Innovation Seed Fund 2025-26

The purpose of the Innovation Seed Fund 2025-26 is to support WA innovators to develop and commercialise their health and medical innovations through start-up companies operating in WA, creating high-value jobs and enhancing the biomedical support and manufacturing capacity of the State.

The funding will be used to support the validation of inventive concepts, the feasibility testing of proposed solutions, and the advancement of developed solutions towards the path of commercialisation within the following streams:

Stream 1 – Devices, diagnostic and digital
The innovation is a device or technology that will prevent, diagnose, treat and/or monitor a health condition that impacts the people of Western Australia. This includes but is not limited to novel equipment, digital tools, and medical implants that aim to improve the safety, effectiveness, access, timeliness and/or cost as compared with existing practice.

Stream 2 – Therapeutics and vaccines
The innovation is a drug, compound or medical biologic that will prevent, detect, or treat a health condition that impacts the people of Western Australia. This includes but is not limited to novel medicines, vaccines, immune modulators and other medical products derived from chemical or biological material that aim to improve safety, quality, access or patient outcomes as compared with existing practice.

Program Status: Open for Applications

Expression of Interest applications due: 1:00pm (AWST), Thursday 22 January 2026

The Innovation Seed Fund 2025-26 Guidelines and Conditions can be accessed below:

The Application Form can be accessed and submitted via the Department of Health Grant Management System
Any queries related to the program can be directed to the Department of Health, Office of Medical Research and Innovation at DoH.OMRI@health.wa.gov.au. 
Information on other FHRI Fund programs can be accessed by subscribing to updates or checking the FHRI Fund current opportunities.